Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

Overview

Metastatic breast cancer (MBC) is an incurable disease. Maintaining optimum quality of life is a major goal of care. There is a strong body of evidence that exercise can reduce or manage fatigue, depression and insomnia in breast cancer patients; however, the evidence base is overwhelmingly in early stage cancer patients. The purpose of this study is to see if a home-based, self-directed walking program can have similar benefits in women with an MBC diagnosis. The primary objective is to evaluate whether engagement in physical activity will reduce fatigue during active treatment for MBC (baseline to 3 months); this is the primary endpoint. Secondary objectives pertain to feasibility of recruitment and retention of study participants and measuring changes between baseline, 3 months and 6 months in additional quality of life measures. Exploratory analyses pertain to changes in p16INK4a levels and sarcopenia between baseline and 3 months. The design is a single arm intervention trial in 30 patients. Findings from this study will provide preliminary data for a grant application to test the physical activity intervention in a randomized controlled trial (RCT) in a large sample of women with metastatic breast cancer.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2019

Interventions

  • Behavioral: Walk with Ease

Arms, Groups and Cohorts

  • Experimental: single arm
    • Walk with Ease physical activity intervention

Clinical Trial Outcome Measures

Primary Measures

  • changes in fatigue scores
    • Time Frame: at 3 months
    • Evaluate change in PROMIS Fatigue scores from baseline to 3 months

Participating in This Clinical Trial

Inclusion Criteria

  • Female – Age 21 or older – Metastatic breast cancer (MBC) diagnosis – Stage IV – Receiving treatment regimen for MBC, but no more than 3 previous chemotherapy or biologic regimens – Approval from the treating clinician to engage in moderate-intensity physical activity. – Patient-assessed ability to walk and engage in moderate physical activity – Proficient in English. – IRB approved signed written informed consent. – Willing and able to do all study requirements. Exclusion Criteria:

  • One or more significant medical conditions or other issues that in the physician's judgment preclude participation in the walking intervention. – No more than 3 prior chemotherapy regimens.

Gender Eligibility: Female

Minimum Age: 21 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • UNC Lineberger Comprehensive Cancer Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Kirsten A Nyrop, PhD, Principal Investigator, UNC Lineberger Comprehensive Cancer Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.